Results 21 to 30 of about 4,530 (213)

Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy [PDF]

, 2012
Several colorectal cancer-screening tests are available, but it is uncertain which provides the best balance of risks and benefits within a screening programme. We evaluated cost-effectiveness of a population-based screening programme in Ireland based on
Tappenden, P., P Tappenden, L Sharp, Staines, Anthony, Walsh, Cathal Dominic, Cara Usher (3413333), Paul Tappenden (7546178), Cathal Dominic Walsh (12583351), Usher, C., A O'Ceilleachair, Sophie Whyte (3463898), O'Ceilleachair, A., Sharp, L., M Barry, O\u27Ceilleachair, Alan, A Staines, Walsh, C., Comber, Harry, Alan O'Ceilleachair (12583354), H Comber, Chilcott, J., Michael Barry (3413330), Whyte, Sophie, J Chilcott, Anthony Staines (464527), Tappenden, Paul, Whyte, S., Chilcott, James, Barry, M., C Walsh, Sharp, Linda, Barry, Michael, Staines, A., Tilson, L., Comber, H., Tilson, Lesley, Usher, Cara, S Whyte, Linda Sharp (93718), C Usher, Harry Comber (452912), Lesley Tilson (7944662), James Chilcott (5849891), L Tilson   +43 more
core   +1 more source

The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening.

PLoS ONE, 2014
BackgroundThe clinical benefit of guaiac fecal occult blood tests (FOBT) is now well established for colorectal cancer screening. Growing evidence has demonstrated that epigenetic modifications and fecal microbiota changes, also known as dysbiosis, are ...
Aurelien Amiot, Hicham Mansour, Isabelle Baumgaertner, Jean-Charles Delchier, Christophe Tournigand, Jean-Pierre Furet, Jean-Pierre Carrau, Florence Canoui-Poitrine, Iradj Sobhani, CRC group of Val De Marne   +9 more
doaj   +1 more source

Current implications and challenges of artificial intelligence technologies in therapeutic intervention of colorectal cancer

Exploration of Targeted Anti-tumor Therapy, 2023
Irrespective of men and women, colorectal cancer (CRC), is the third most common cancer in the population with more than 1.85 million cases annually. Fewer than 20% of patients only survive beyond five years from diagnosis.
Kriti Das, Maanvi Paltani, Pankaj Kumar Tripathi, Rajnish Kumar, Saniya Verma, Subodh Kumar, Chakresh Kumar Jain   +6 more
doaj   +1 more source

Quantifying the duration of the preclinical detectable phase in cancer screening: a systematic review [PDF]

Epidemiology and Health, 2022
OBJECTIVES The aim of this study was to provide an overview of published mathematical estimation approaches to quantify the duration of the preclinical detectable phase (PCDP) using data from cancer screening programs.
Sandra M. E. Geurts, Anne M. W. M. Aarts, André L. M. Verbeek, Tony H. H. Chen, Mireille J. M. Broeders, Stephen W. Duffy   +5 more
doaj   +1 more source

Histological and biochemical evidence for an intravital stab wound on Ötzi´s right hand

Journal of Biological Research, 2021
On careful re-examination of the mummy a small irregularly shaped 3.7 cm long, deep, dark brown coloured stab wound was detected on Ötzi´s right hand extending from the palmar hand to the lateral back of the hand.
Andreas G. Nerlich, Beatrice E. Bachmeier, Albert Zink, Eduard Egarter-Vigl   +3 more
doaj   +1 more source

Colorectal Cancer Screening—Who, How, and When? [PDF]

Clinical Endoscopy, 2018
Colorectal cancer (CRC) is the third most common cancer worldwide. It is amenable to screening as it occurs in premalignant, latent, early, and curable stages.
Roisin Bevan, Matthew D Rutter
doaj   +1 more source

Review of economic evidence in the prevention and early detection of colorectal cancer. [PDF]

, 2013
This paper aims to systematically review the cost-effectiveness evidence, and to provide a critical appraisal of the methods used in the model-based economic evaluation of CRC screening and subsequent surveillance.
Kim E Jeong, Cairns, John A, Jeong, Kim E., John A Cairns, Jeong, Kim E, Cairns, John A.   +5 more
core   +1 more source

Guaiac VS Immunochemical Tests: Faecal Occult Blood Test Screening for Colorectal Cancer in a Rural Community

, 2005
Objective: To describe patient participation and clinical performance in a colorectal cancer (CRC) screening program utilising faecal occult blood test (FOBT).\ud \ud Methods: A community-based intervention was conducted in a small, rural community in ...
Tong, Shilu, Stanton, Warren R., Del Mar, Christopher, Monika Janda, Alexandra Clavarino, Clavarino, Alexandra, Masson, John, Stephen Fairley, John Croese, Stanton, Warren, Beth Newman, Shilu Tong, Warren R. Stanton, Joanne Aitkne, Fairley, Stephen, Leggett, Barbara, Christopher Del Mar, Hughes, Karen, Croese, John, John Masson, Aitken, Joanne, Janda, Monika, Karen Hughes, Newman, Beth, Barbara Leggett   +24 more
core   +1 more source

Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know

, 2015
Although colorectal cancer (CRC) is a common cause of cancer-related death, it is fortunately amenable to screening with faecal tests for occult blood and endoscopic tests.
Tinmouth, J, Allison, JE, Lansdorp - Vogelaar, Iris   +2 more
core   +2 more sources

Colorectal cancer screening: tests, strategies and perspectives

Frontiers in Public Health, 2014
Screening has a central role in colorectal cancer (CRC) control. Different screening tests are effective in reducing CRC-specific mortality. Influence on cancer incidence depends on test sensitivity for premalignant lesions, ranging from almost no ...
Fabrizio eStracci, Fabrizio eStracci, Manuel eZorzi, Grazia eGrazzini   +3 more
doaj   +1 more source